08/07/2025
6:15 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/29/2025
3:15 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/29/2025
10:22 AM | Aclaris Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G | |
07/24/2025
3:21 PM | Aclaris Therapeutics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SCHEDULE 13G/A | |
07/17/2025
6:44 PM | Aclaris Therapeutics (Subject)
BlackRock, Inc. (Filed by)
| Form SCHEDULE 13G | |
06/30/2025
5:59 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/09/2025
3:20 PM | Aclaris Therapeutics (Issuer)
Molineaux Christopher P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
3:20 PM | Aclaris Therapeutics (Issuer)
GOWEN MAXINE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
3:20 PM | Aclaris Therapeutics (Issuer)
Humphries William D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
3:20 PM | Aclaris Therapeutics (Issuer)
Mehra Anand (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
3:20 PM | Aclaris Therapeutics (Issuer)
MILANO VINCENT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ACRS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Aclaris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
06/09/2025
3:20 PM | Aclaris Therapeutics (Issuer)
SCHIFF ANDREW N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
4:01 PM | Aclaris Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/15/2025
9:45 AM | Aclaris Therapeutics (Subject)
Rock Springs Capital Management LP (Filed by)
| Form SCHEDULE 13G/A | |
05/12/2025
8:07 AM | Aclaris Therapeutics (Subject)
Adage Capital Management, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
05/08/2025
3:30 PM | Aclaris Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2025
6:15 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/05/2025
3:32 PM | Aclaris Therapeutics (Issuer)
Hall Jesse Wayne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
3:00 PM | Aclaris Therapeutics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SCHEDULE 13G | |
04/24/2025
6:00 AM | Aclaris Therapeutics (Filer)
| Form DEF 14A | |
04/24/2025
6:01 AM | Aclaris Therapeutics (Filer)
| Form DEFA14A | |
04/24/2025
6:01 AM | Aclaris Therapeutics (Filer)
| Form ARS | |
03/09/2025
11:15 PM | Aclaris Therapeutics (Filer)
| Form EFFECT | |
02/27/2025
3:30 PM | Aclaris Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2025
6:17 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2025
1:26 PM | Aclaris Therapeutics (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
02/12/2025
8:31 AM | Aclaris Therapeutics (Subject)
Adage Capital Management, L.P. (Filed by)
| Form SCHEDULE 13G | |
01/13/2025
6:00 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2025
5:25 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
5:25 PM | Aclaris Therapeutics (Issuer)
Loerop James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
5:25 PM | Aclaris Therapeutics (Issuer)
Balthaser Kevin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
5:25 PM | Aclaris Therapeutics (Issuer)
Monahan Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/01/2025
11:15 PM | Aclaris Therapeutics (Filer)
| Form EFFECT | |
12/31/2024
3:15 PM | Aclaris Therapeutics (Filer)
| Form 424B3 | |
12/19/2024
3:31 PM | Aclaris Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
12/12/2024
3:15 PM | Aclaris Therapeutics (Issuer)
Monahan Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
3:15 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2024
7:06 AM | Aclaris Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
12/03/2024
4:42 PM | Aclaris Therapeutics (Issuer)
Davis Hugh M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
3:02 PM | Aclaris Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/25/2024
10:02 AM | Aclaris Therapeutics (Subject)
Biosion, Inc. (Filed by)
| Form SC 13G | |
A New Way to Double Your Retirement Income? (Ad) Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boom. For retirees, that could mean a way to generate reliable monthly income—without the outdated 4% withdrawal rule, risky trading, or high-fee annuities.
If you’re ready to stop worrying about money running out and start enjoying the freedom to cover expenses, treat loved ones, and live life on your terms, this may be exactly what you’ve been waiting for. Click here to see how to turn your savings into a monthly income machine. |
11/25/2024
10:03 AM | Aclaris Therapeutics (Issuer)
Biosion, Inc. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/21/2024
3:51 PM | Aclaris Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SC 13G | |
11/20/2024
3:20 PM | Aclaris Therapeutics (Issuer)
Mehra Anand (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2024
3:20 PM | Aclaris Therapeutics (Issuer)
Davis Hugh M. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/18/2024
7:15 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
6:21 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2024
3:18 PM | Aclaris Therapeutics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
10/03/2024
3:15 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
6:52 PM | Aclaris Therapeutics (Issuer)
Balthaser Kevin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
4:08 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
MarketBeat All Access